Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nikki Gurley"'
Autor:
Jessica A. Fleming, Nikki Gurley, Sophia Knudson, Lassane Kabore, John Tanko Bawa, Patience Dapaah, Sandeep Kumar, Surendra Uranw, Thang Tran, Le Thi Phuong Mai, Chris Odero, Christopher Obong'o, Kofi Aburam, Stella Wanjiru, Nguyen Thi My Hanh, Luu Phuong Dung, William P. Hausdorff
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100368- (2023)
Background: Shigella is the leading bacterial cause of diarrheal mortality in children and can cause long-term effects on growth and development. No licensed Shigella vaccines currently exist but several promising candidates are in development and co
Externí odkaz:
https://doaj.org/article/364a0bdd68144cada3bfec9ec8314b1c
Autor:
Jessica Price, Nikki Gurley, Margaret Gyapong, Evelyn Korkor Ansah, Kofi Awusabo-Asare, Samuel Fosu Gyasi, Pearson Nkhoma, Alinane Linda Nyondo-Mipando, George Okello, Jayne Webster, Nicola Desmond, Jenny Hill, W. Scott Gordon
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1801 (2023)
Background: The WHO recommended the use of the RTS,S/AS01 malaria vaccine (RTS,S) based on a pilot evaluation in routine use in Ghana, Kenya, and Malawi. A longitudinal qualitative study was conducted to examine facilitators and barriers to uptake of
Externí odkaz:
https://doaj.org/article/8cd3224c1cfe465583ad7daae90707b6
Autor:
Jessica Mooney, Jessica Price, Carolyn Bain, John Tanko Bawa, Nikki Gurley, Amresh Kumar, Guwani Liyanage, Rouden Esau Mkisi, Chris Odero, Karim Seck, Evan Simpson, William P Hausdorff
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0270369 (2022)
BackgroundLive oral rotavirus vaccines (LORVs) have significantly reduced rotavirus hospitalizations and deaths worldwide. However, LORVs are less effective in low- and middle-income countries (LMICs). Next-generation rotavirus vaccines (NGRVs) may b
Externí odkaz:
https://doaj.org/article/100843d34bd441baa37c3f57481f3e83
Autor:
Rouden Esau Mkisi, Evan Simpson, Guwani Liyanage, William P. Hausdorff, Karim Seck, Chris Odero, Jessica Price, Carolyn Bain, Nikki Gurley, Amresh Kumar, John Bawa, Jessica Mooney
Publikováno v:
Vaccine
Highlights • An effective and affordable injectable rotavirus vaccine may be attractive to LMICs. • Co-administering oral and injectable vaccines is acceptable to many stakeholders. • Oral vaccine with a birth dose is favored over a higher cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b694595c9b16f5945451b51b061d2f41
https://doi.org/10.1016/j.vaccine.2021.11.009
https://doi.org/10.1016/j.vaccine.2021.11.009
Autor:
Nikki, Gurley, Elan, Ebeling, Ashley, Bennett, Jean-Jacques Kayembe, Kashondo, Victoria Ayano, Ogawa, Clemence, Couteau, Claire, Felten, Naakesh, Gomanie, Pauline, Irungu, Katharine D, Shelley, Jessica C, Shearer
Publikováno v:
Bulletin of the World Health Organization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37edefec327f0b6f34267ad033c27ad6
https://doi.org/10.2471/blt.21.286852
https://doi.org/10.2471/blt.21.286852
Autor:
Jessica Shearer, Herbert C. Duber, Shakilah N Nagasha, Gilbert Asiimwe, Emily Carnahan, Carol Kamya, Baltazar Chilundo, Katharine D. Shelley, David Phillips, Godefroid Mpanya, Adama Faye, Nicole Salisbury, Nikki Gurley
Publikováno v:
Global Health: Science and Practice
Lessons learned from implementing evaluations for Gavi, the Vaccine Alliance and the Global Fund for AIDS, Tuberculosis, and Malaria can help inform the design and implementation of ongoing or future evaluations of complex interventions. We share 5 l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0ab36a22f723789ec20c3450c28d28
https://doi.org/10.9745/ghsp-d-20-00126
https://doi.org/10.9745/ghsp-d-20-00126
Autor:
Jessica Mooney, Jessica Price, Carolyn Bain, John Tanko Bawa, Nikki Gurley, Amresh Kumar, Guwani Liyanage, Rouden Esau Mkisi, Chris Odero, Karim Seck, Evan Simpson, William P. Hausdorff
Publikováno v:
PloS one. 17(6)
Background Live oral rotavirus vaccines (LORVs) have significantly reduced rotavirus hospitalizations and deaths worldwide. However, LORVs are less effective in low- and middle-income countries (LMICs). Next-generation rotavirus vaccines (NGRVs) may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9b43776aad32831c6e6a6b1c6ccff7
https://pubmed.ncbi.nlm.nih.gov/35737718
https://pubmed.ncbi.nlm.nih.gov/35737718
